James M O’Brien's most recent trade in Cognition Therapeutics Inc was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 23, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cognition Therapeutics Inc | James M. O’Brien | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
Cognition Therapeutics Inc | James M. O’Brien | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 13 Oct 2021 | 5,000 | 5,000 | - | 12 | 60,000 | Common Stock |
Cognition Therapeutics Inc | James M. O’Brien | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 54,457 | 54,457 | - | - | Stock Option (right to buy) |